Skip to main content

Table 3 Six-month diabetes treatment outcome in Syrian patients, Shatila primary care clinic, Beirut, Lebanon, 2016–2017

From: Treating Syrian refugees with diabetes and hypertension in Shatila refugee camp, Lebanon: Médecins Sans Frontières model of care and treatment outcomes

 

Baseline HbA1C

Six month HbA1C

p-valuea

HbA1C % - [mean (SD); min-max]

 Type-1 DM (n = 20)

9.3 (1.8); 6.0–12.6

8.4 (1.4); 6.7–12.3

0.022

 Type-2 DM (n = 23)

9.4 (2.5); 5.8–14.4

8.1 (1.8); 5.7–12.7

0.001

 DM and HTN (n = 22)

9.0 (2.0); 5.7–12.9

7.7 (1.6); 5.5–11.8

0.003

HbA1C < 8% - [n (%)]

 Type-1 DM (n = 20)

4 (20)

11 (55)

0.016

 Type-2 DM (n = 23)

8 (35)

15 (65)

0.016

 DM and HTN (n = 22)

7 (32)

14 (64)

0.039

  1. DM diabetes mellitus, HTN hypertension, SD standard deviation
  2. ap-value <0.05 is statistically significant; Wilcoxon signed rank tests for mean and McNemar tests for proportions